|
AGGF1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.70899999999819E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.032000E-04 |
| Normal-vs-Stage2 |
3.129700E-02 |
| Normal-vs-Stage3 |
1.55004999999875E-05 |
| Normal-vs-Stage4 |
1.5090999999634E-06 |
| Stage1-vs-Stage2 |
4.967600E-01 |
| Stage1-vs-Stage3 |
9.047600E-02 |
| Stage1-vs-Stage4 |
2.510500E-02 |
| Stage2-vs-Stage3 |
6.917900E-02 |
| Stage2-vs-Stage4 |
1.704060E-02 |
| Stage3-vs-Stage4 |
3.539800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.61380000000189E-05 |
| Normal-vs-AfricanAmerican |
3.602200E-02 |
| Normal-vs-Asian |
7.676800E-03 |
| Caucasian-vs-AfricanAmerican |
5.297600E-01 |
| Caucasian-vs-Asian |
5.221800E-01 |
| AfricanAmerican-vs-Asian |
8.989600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.09040000000083E-05 |
| Normal-vs-Female |
1.750180E-04 |
| Male-vs-Female |
4.609800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.861520E-03 |
| Normal-vs-Age(41-60Yrs) |
1.762160E-04 |
| Normal-vs-Age(61-80Yrs) |
3.50780000002437E-06 |
| Normal-vs-Age(81-100Yrs) |
5.025700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.010400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.228400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.575200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.803400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.191800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.086600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.124470E-03 |
| Classical-VS-Follicular |
4.097700E-02 |
| Classical-VS-Other |
2.992200E-01 |
| Classical-VS-Normal |
2.520700E-03 |
| Tall-VS-Follicular |
1.678820E-01 |
| Tall-VS-Other |
7.551400E-01 |
| Tall-VS-Normal |
4.0169999999673E-06 |
| Follicular-VS-Other |
7.322200E-01 |
| Follicular-VS-Normal |
8.05130000000043E-05 |
| Other-VS-Normal |
2.955900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.182300E-04 |
| Normal-vs-N1 |
2.154200E-04 |
| N0-vs-N1 |
3.449400E-01 |
|
|
